Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Metastatic prostate cancer

  • You have access
    Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
    NAOTO WAKITA, TAKUTO HARA, KOTARO SUZUKI, TOMOAKI TERAKAWA, JUN TEISHIMA, YUZO NAKANO and HIDEAKI MIYAKE
    Anticancer Research June 2024, 44 (6) 2627-2635; DOI: https://doi.org/10.21873/anticanres.17069
  • You have access
    Treatment Results of High-dose-rate Brachytherapy and External Beam Radiation With Long-term Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer
    HIROTAKA SUZUKI, FUMIHIKO URABE, KOSUKE IWATANI, KEIICHIRO MIYAJIMA, YU IMAI, KOJIRO TASHIRO, SHUNSUKE TSUZUKI, MARIKO HONDA, YUSUKE KOIKE, MANABU AOKI, SHUN SATO, HIROYUKI TAKAHASHI, KENTA MIKI and TAKAHIRO KIMURA
    Anticancer Research July 2023, 43 (7) 3135-3143; DOI: https://doi.org/10.21873/anticanres.16486
  • You have access
    Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer
    CARSTEN NIEDER and LUKA STANISAVLJEVIC
    Anticancer Research July 2022, 42 (7) 3675-3679; DOI: https://doi.org/10.21873/anticanres.15856
  • You have access
    Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer
    TAKESHI KOBAYASHI, RYO NAMITOME, YU HIRATA, MASAKI SHIOTA, KENJIRO IMADA, EIJI KASHIWAGI, ARIO TAKEUCHI, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI and MASATOSHI ETO
    Anticancer Research June 2019, 39 (6) 3191-3195; DOI: https://doi.org/10.21873/anticanres.13457
  • You have access
    Suppression of Taxanes Cytotoxicity by Citrus Flavonoid Hesperetin in PPC-1 Human Prostate Cancer Cells
    KATRIN SAK, HELEN LUST, MARJU KASE, MARIKA SAAR and JANA JAAL
    Anticancer Research November 2018, 38 (11) 6209-6215; DOI: https://doi.org/10.21873/anticanres.12975
  • You have access
    Image-guided Stereotactic Body Radiotherapy in Metastatic Prostate Cancer
    FRANCESCO PASQUALETTI, MARCO PANICHI, ALDO SAINATO, DAVIDE BALDACCINI, PAOLA COCUZZA, ALESSANDRA GONNELLI, SABRINA MONTRONE, ALESSANDRO MOLINARI, SARA BARBIERO, ANDREA BRUSCHI, ELISA NOTINI, STEFANO URSINO, VALENTINA MAZZOTTI, RICCARDO MORGANTI, GABRIELE CORAGGIO, MARTINA CANTARELLA, PAOLA ANNA ERBA and FABIOLA PAIAR
    Anticancer Research May 2018, 38 (5) 3119-3122;
  • You have access
    Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation
    TIMO JOENSUU, GREETTA JOENSUU, KALEVI KAIREMO, TIMO KILJUNEN, MAIGO RIENER, AILI AALTONEN, MARTTI ALA-OPAS, AKI KANGASMÄKI, TUOMO ALANKO, LAURI TAIPALE, PETTERI HERVONEN, ANNA BÜTZOW, IRENE VIRGOLINI and AKSELI HEMMINKI
    Anticancer Research December 2016, 36 (12) 6439-6447;
  • You have access
    Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer
    MASAKI SHIOTA, ARIO TAKEUCHI, MASAAKI SUGIMOTO, EIJI KASHIWAGI, TAKASHI DEJIMA, KEIJIRO KIYOSHIMA, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI and AKIRA YOKOMIZO
    Anticancer Research December 2015, 35 (12) 6925-6932;
  • You have access
    Predictive Factors for Response to Abiraterone in Metastatic Castration Refractory Prostate Cancer
    MEHRAN AFSHAR, FAWAZ AL-ALLOOSH, SARAH PIRRIE, CLARE ROWAN, NICHOLAS D. JAMES and EMILIO PORFIRI
    Anticancer Research February 2015, 35 (2) 1057-1063;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire